Brain 17 Vienna

Tumours responsive to systemic treatment

brain metastases

Potential trial design • Tumour specific • Biomarker specific • Timing of disease specific

systemic therapy CR/good PR

randomise

whole brain radiotherapy

surveillance

Role of radiotherapy in responsive tumours